Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Firouzi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advances in Cardiology|May 2, 2006
Cx40 polymorphism in human atrial fibrillationRichard N W Hauer, W Antoinette Groenewegen, Mehran Firouzi, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 15, 2020
Reducing radiation exposure in second-generation cryoballoon ablation without compromising clinical outcomeMarijn J Holl, Rohit E Bhagwandien, Mehran Firouzi, et al.
Biochimica Et Biophysica Acta|October 20, 2006
The human Cx40 promoter polymorphism -44G-->A differentially affects transcriptional regulation by Sp1 and GATA4Mehran Firouzi, Marti F A Bierhuizen, Bart Kok, et al.
Circulation Research|August 7, 2004
Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillationMehran Firouzi, Hemanth Ramanna, Bart Kok, et al.
International Journal of Cardiology. Heart & Vasculature|January 8, 2024
Incidence of ventricular arrhythmias in patients with chronic total coronary occlusion: Results of the VACTOR studyAmira Assaf, Rafi Sakhi, Roberto Diletti, et al.
Journal of Hypertension|March 2, 2006
Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in menMehran Firouzi, Bart Kok, Wilko Spiering, et al.
Circulation Research|January 11, 2003
A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstillW Antoinette Groenewegen, Mehran Firouzi, Connie R Bezzina, et al.
Journal of the American Heart Association|April 9, 2024
Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter-Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO-IT)) RegistryAnna van Veelen, Tom E Verstraelen, Yvemarie B O Somsen, et al.
European Heart Journal Open|June 12, 2026
Design and rationale of the RISC-trial: multicentre <i>R</i>CT to assess <i>i</i>mmediate discharge of <i>s</i>yncope patients admitted to the (<i>c</i>ardiac) emergency roomThomas T Boel, Suzanne Y G Peeters, Anouk P van Alem, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 14, 2021
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac deathTom E Verstraelen, Marit van Barreveld, Pascal H F M van Dessel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advances in Cardiology|May 2, 2006
Cx40 polymorphism in human atrial fibrillationRichard N W Hauer, W Antoinette Groenewegen, Mehran Firouzi, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 15, 2020
Reducing radiation exposure in second-generation cryoballoon ablation without compromising clinical outcomeMarijn J Holl, Rohit E Bhagwandien, Mehran Firouzi, et al.
Biochimica Et Biophysica Acta|October 20, 2006
The human Cx40 promoter polymorphism -44G-->A differentially affects transcriptional regulation by Sp1 and GATA4Mehran Firouzi, Marti F A Bierhuizen, Bart Kok, et al.
Circulation Research|August 7, 2004
Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillationMehran Firouzi, Hemanth Ramanna, Bart Kok, et al.
International Journal of Cardiology. Heart & Vasculature|January 8, 2024
Incidence of ventricular arrhythmias in patients with chronic total coronary occlusion: Results of the VACTOR studyAmira Assaf, Rafi Sakhi, Roberto Diletti, et al.
Journal of Hypertension|March 2, 2006
Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in menMehran Firouzi, Bart Kok, Wilko Spiering, et al.
Circulation Research|January 11, 2003
A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstillW Antoinette Groenewegen, Mehran Firouzi, Connie R Bezzina, et al.
Journal of the American Heart Association|April 9, 2024
Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter-Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO-IT)) RegistryAnna van Veelen, Tom E Verstraelen, Yvemarie B O Somsen, et al.
European Heart Journal Open|June 12, 2026
Design and rationale of the RISC-trial: multicentre <i>R</i>CT to assess <i>i</i>mmediate discharge of <i>s</i>yncope patients admitted to the (<i>c</i>ardiac) emergency roomThomas T Boel, Suzanne Y G Peeters, Anouk P van Alem, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 14, 2021
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac deathTom E Verstraelen, Marit van Barreveld, Pascal H F M van Dessel, et al.
Pageof 1